Immediate Impact
62 standout
Citing Papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
Works of Andrés Muñoz being referenced
YOSEMITE: A 3 arm double-blind randomized phase 2 study of gemcitabine, paclitaxel protein-bound particles for injectable suspension, and placebo (GAP) versus gemcitabine, paclitaxel protein-bound particles for injectable suspension and either 1 or 2 truncated courses of demcizumab (GAD)
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Andrés Muñoz | 176 | 8 | 48 | 70 | 18 | 222 | |
| F. Espósito | 90 | 14 | 32 | 37 | 23 | 204 | |
| Axel Florschütz | 190 | 65 | 54 | 104 | 16 | 242 | |
| Yvonne Perner | 231 | 2 | 27 | 187 | 26 | 274 | |
| Karin Menhart | 54 | 16 | 50 | 36 | 22 | 243 | |
| Akimichi Imamura | 127 | 34 | 82 | 56 | 20 | 267 | |
| Merete Krogh | 189 | 19 | 27 | 41 | 17 | 222 | |
| Maria Antista | 188 | 9 | 65 | 52 | 25 | 274 | |
| Bahiyah E. Haji | 81 | 92 | 70 | 15 | 249 | ||
| Audrey Lardy-Cléaud | 107 | 14 | 68 | 26 | 17 | 155 | |
| Elena Mata | 140 | 12 | 34 | 41 | 14 | 191 |
All Works
Loading papers...